Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The NOFO is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this NOFO include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecu
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
11/06/2024
Closes
2026-09-07
Eligibility
Eligibility
Independent school districtsNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSpecial district governmentsPublic housing authorities/Indian housing authoritiesCity or township governmentsNative American tribal governments (Federally recognized)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)State governmentsPublic and State controlled institutions of higher educationSmall businessesCounty governmentsFor profit organizations other than small businesses
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-153
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov